Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
INVENTIVA
Inventiva to Present Multiple Abstracts at Paris MASH 2026
September 8, 2026
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
September 2, 2026
Inventiva Appoints Chris Benecchi as Chief Operating Officer
August 31, 2026
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
July 30, 2026
Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
July 29, 2026
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
July 9, 2026
Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026
July 2, 2026
Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout
June 2, 2026
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
June 2, 2026
Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris
June 2, 2026
1
2
Next Page
→